<h3>
Answer:</h3>
Debiting salaries Expense $400 and Crediting Salaries payable $400.
<h3>
Explanation:</h3>
We are given;
1 employees earns $ 100 a day
Therefore;
2 employees will earn $ 200 a day
The month ends on Tuesday, but the two employees works on Monday and Tuesday.
- Therefore, the month-end adjusting entry to record will be the amount earned by the two employees on the two days.
Two employees for 2 days = $200/day × 2 days
= $400
- But, salary is an expense, and in the accounts an increase in expense account is debited.
- According to the rule of double entry, an increase in salaries expense decreases the salaries payable. Therefore, we debit salaries expense account and credit salaries payable account.
- Therefore, the month-end adjusting entry to record the salaries earned but unpaid would be;
Debiting salaries Expense $400 and Crediting Salaries payable $400.
Answer:
the elimination of competition
Explanation:
Answer:
C) information based strategies
Explanation:
Based on the information provided within the question it seems that this work-life initiative used by Biozone falls under the category of information based strategies. These are strategies that focus on improving employee work flow and efficiency by providing them with benefits and activities that increase their knowledge base, such as skills workshops and networking sessions that can lead to good work relationships with people in the same industry to rely upon.
Answer:
The correct answer is option B.
Explanation:
The statement "There is no free lunch" means that no product is made for free. Production of any good or service requires resources. These resources are scarce and have alternative uses. So in order to produce any goods or services limited resources are used and its alternative uses are sacrificed.
Answer: credible commitment
Explanation:
From the question, we are informed that BioGrow Pharma Inc. wanted its research partner, an R&D company, to develop a cancer vaccine but that the project required huge capital investments, and its research partner was not ready to solely face the risks involved.
Therefore, to gain its partner's confidence and to prove its involvement, BioGrow Pharma invested $100 million in the project. This investment made by BioGrow Pharma will result in a credible commitment.
